Driver genes play a critical role in glioblastoma evolution, and frequent mutations in TP53, EGFR, PTEN, and TERT genes have been well-defined.9,18,19 We analyzed SNVs to observe the frequency and alterations of recognized glioblastoma drivers in hypermetabolic lesions. This evidence concerns the gene PTEN and glioblastoma.